192 related articles for article (PubMed ID: 32473487)
1. Targeting mitochondrial calcium pathways as a potential treatment against Parkinson's disease.
Dey K; Bazala MA; Kuznicki J
Cell Calcium; 2020 Jul; 89():102216. PubMed ID: 32473487
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial calcium imbalance in Parkinson's disease.
Ludtmann MHR; Abramov AY
Neurosci Lett; 2018 Jan; 663():86-90. PubMed ID: 28838811
[TBL] [Abstract][Full Text] [Related]
3. LRRK2 deficiency induced mitochondrial Ca
Ludtmann MHR; Kostic M; Horne A; Gandhi S; Sekler I; Abramov AY
Cell Death Dis; 2019 Mar; 10(4):265. PubMed ID: 30890692
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants.
Verma M; Callio J; Otero PA; Sekler I; Wills ZP; Chu CT
J Neurosci; 2017 Nov; 37(46):11151-11165. PubMed ID: 29038245
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.
Calì T; Ottolini D; Brini M
Biofactors; 2011; 37(3):228-40. PubMed ID: 21674642
[TBL] [Abstract][Full Text] [Related]
6. Current perspective of mitochondrial biology in Parkinson's disease.
Ammal Kaidery N; Thomas B
Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
[TBL] [Abstract][Full Text] [Related]
7. Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness.
Cieri D; Brini M; Calì T
Biochem Biophys Res Commun; 2017 Feb; 483(4):1020-1030. PubMed ID: 27581196
[TBL] [Abstract][Full Text] [Related]
8. A mitochondrial inside-out iron-calcium signal reveals drug targets for Parkinson's disease.
Bharat V; Durairaj AS; Vanhauwaert R; Li L; Muir CM; Chandra S; Kwak CS; Le Guen Y; Nandakishore P; Hsieh CH; Rensi SE; Altman RB; Greicius MD; Feng L; Wang X
Cell Rep; 2023 Dec; 42(12):113544. PubMed ID: 38060381
[TBL] [Abstract][Full Text] [Related]
9. Calcium homeostasis, selective vulnerability and Parkinson's disease.
Chan CS; Gertler TS; Surmeier DJ
Trends Neurosci; 2009 May; 32(5):249-56. PubMed ID: 19307031
[TBL] [Abstract][Full Text] [Related]
10. Functional properties and mode of regulation of the mitochondrial Na
Kostic M; Sekler I
Semin Cell Dev Biol; 2019 Oct; 94():59-65. PubMed ID: 30658153
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson's disease.
Rasheed MZ; Tabassum H; Parvez S
Protoplasma; 2017 Jan; 254(1):33-42. PubMed ID: 26825389
[TBL] [Abstract][Full Text] [Related]
12. Altered ER-mitochondria contact impacts mitochondria calcium homeostasis and contributes to neurodegeneration in vivo in disease models.
Lee KS; Huh S; Lee S; Wu Z; Kim AK; Kang HY; Lu B
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8844-E8853. PubMed ID: 30185553
[TBL] [Abstract][Full Text] [Related]
13. The origins of oxidant stress in Parkinson's disease and therapeutic strategies.
Surmeier DJ; Guzman JN; Sanchez-Padilla J; Goldberg JA
Antioxid Redox Signal; 2011 Apr; 14(7):1289-301. PubMed ID: 20712409
[TBL] [Abstract][Full Text] [Related]
14. Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.
Surmeier DJ; Halliday GM; Simuni T
Exp Neurol; 2017 Dec; 298(Pt B):202-209. PubMed ID: 28780195
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial VDAC, the Na
Shoshan-Barmatz V; De S
Adv Exp Med Biol; 2017; 981():323-347. PubMed ID: 29594867
[TBL] [Abstract][Full Text] [Related]
16. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
Zuo L; Motherwell MS
Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
[TBL] [Abstract][Full Text] [Related]
17. Targeting calcium homeostasis and impaired inter-organelle crosstalk as a potential therapeutic approach in Parkinson's disease.
Kaur S; Sehrawat A; Mastana SS; Kandimalla R; Sharma PK; Bhatti GK; Bhatti JS
Life Sci; 2023 Oct; 330():121995. PubMed ID: 37541578
[TBL] [Abstract][Full Text] [Related]
18. Emerging concepts of mitochondrial dysfunction in Parkinson's disease progression: Pathogenic and therapeutic implications.
Rani L; Mondal AC
Mitochondrion; 2020 Jan; 50():25-34. PubMed ID: 31654753
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria: A Therapeutic Target for Parkinson's Disease?
Luo Y; Hoffer A; Hoffer B; Qi X
Int J Mol Sci; 2015 Sep; 16(9):20704-30. PubMed ID: 26340618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
